<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03632564</url>
  </required_header>
  <id_info>
    <org_study_id>SMC-5167-18</org_study_id>
    <nct_id>NCT03632564</nct_id>
  </id_info>
  <brief_title>Modulation of Brain Blood Flow Using Dichoptic Visual and Auditory Stimulation</brief_title>
  <official_title>Modulation of Brain Blood Flow Using Dichoptic Visual and Auditory Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Visior Technologies Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Visior Technologies Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Modulation of brain blood flow using dichoptic Visual and Auditory stimulation using REVIVIEW
      system will be evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The participant will undergo baseline MRI to measure blood flow in the brain for comparison
      later on. After baseline MRI, the participant will observe stimulation using the REVIVIEW
      system for 20 minutes. The content the participants will see is a nature documentary, after
      which the participant will undergo additional MRI imaging to assess the change in blood flow
      in the brain.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 10, 2018</start_date>
  <completion_date type="Anticipated">August 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in blood flow in the brain in respond to the stimulation</measure>
    <time_frame>1 hour</time_frame>
    <description>Evaluate the change in blood flow in different parts of the brain, compared with baseline, after the cessation of stimulation, after 30 minutes and after 60 minutes.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Cerebral Arterial Diseases</condition>
  <arm_group>
    <arm_group_label>Stimulation Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>REVIVIEW dichoptic audio-visual stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>REVIVIEW dichoptic audio-visual stimulation</intervention_name>
    <description>REVIVIEW dichoptic audio-visual stimulation using video goggles</description>
    <arm_group_label>Stimulation Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - healthy subjects

        Exclusion Criteria:

          -  History of brain diseases

          -  Glasses

          -  Diagnosed with Diabetes

          -  Diagnosed with Degenerative brain diseases

          -  Inability to undergo MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Arie Orenstain, Prof.</last_name>
    <phone>972-3-5302993</phone>
    <email>Arie.Orenstain@sheba.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yael Mardor, PhD</last_name>
    <phone>972-3-5302993</phone>
    <email>yael.mardor@sheba.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Yael Mardor, PhD</last_name>
      <phone>97235302993</phone>
      <phone_ext>97235302993</phone_ext>
      <email>yael.mardor@sheba.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Arie Orenstain, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yael Mardor, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 11, 2018</study_first_submitted>
  <study_first_submitted_qc>August 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>August 14, 2018</last_update_submitted>
  <last_update_submitted_qc>August 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Arterial Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

